← SynDRA
WITHAFERIN A
SynDRA canonical compound SYN0011637 — structure-anchored drug synonym record
| Primary target(s) | IKBKB |
|---|
| Mechanism of action | IKK inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- AKT1
- ANXA2
- PTPN2
- PTPN1
- MAPK3
- MAPK1
- KEAP1
- HSPA8
- HSPA6
- GLI1
- CYP1A1
- CHEK2
- CHEK1
- CDK1
- CDC25C
- CASP3
- BRD4
- BRD3
- AURKB
- WEE1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- HLAB
- IFNB1
- KSYK
- NFKB1
- NFKB2
- NSD2
- RELA
- SYK
- TP53
- U17L5
- USP28
- USP30
Cross-references
Synonyms
- NSC-101088
- NSC-273757
- Heat shock factor 1 inhibitor (melanoma), University of Kansas
- HSF-1 inhibitor (melanoma), University of Kansas
- withaferin-a
- Withaferine A
- NSC 101088
- WITHAFERIN DERIV JPR, IOWA U. COMPOUND
- L6DO3QW4K5
- CHEBI:69120
- RefChem:934222
- DTXCID901393128
- MFCD10687098
- NSC101088
- UNII-L6DO3QW4K5
- BRN 1335150
- Withaferin A (Standard)
- WITHAFERIN A [MI]
- 5-19-06-00604 (Beilstein Handbook Reference)
- MLS006010687
- SCHEMBL157208
- orb1301583
- orb3140985
- GTPL13097
- HY-N2065R
- Withaferin A, analytical standard
- Withaferin A, >=95% (HPLC)
- HY-N2065
- BDBM50599323
- EX-A12011
- NSC273757
- s8587
- AKOS040758787
- EBC-460096
- FW32226
- NCGC00180796-02
- NCGC00180796-05
- AS-77575
Look up WITHAFERIN A in the interactive SynDRA portal →